Related Experiment Video
Updated: Jul 11, 2026

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
Effect of artemether on pentobarbitone sleep and electrical activity in rats
Janet I Ejiofor1, Helen O Kwanashie, Joseph A Anuka
1Department of Pharmacology and Clinical Pharmacy, Ahmadu Bello University, PMB 1045, Zaria, 810271, Kaduna State, Nigeria. akanwajane@yahoo.com
Abstract:
Artemether (AM), a highly effective treatment for multidrug-resistant malaria and a component of artemisinin combination therapy, has been associated with some neurotoxicity following repeated high doses. This study was aimed at investigating the effect of AM on pentobarbitone sleep and electrical activities in rats. Wistar rats received AM i.p. at 3 dose levels: 1.5, 7.5, and 15 mg/kg, whereas control rats received 0.2 mL of the vehicle (3% v/v Tween 80). AM administered 20 min before pentobarbitone had no significant effect on the onset and duration of sleep. However, after a 7-day pretreatment, AM dose-dependently prolonged pentobarbitone sleep, as did chloramphenicol. Electroencephalogram and electromyogram recordings 20 min after pretreatment showed that AM (15 mg/kg) exhibited inhibitory activity similar to chlorpromazine as opposed to the excitatory effect of amphetamine. When pretreated for 7 days, rats receiving 1.5 mg/kg AM also showed inhibitory activity of the cortical centres, whereas desynchronization of the optic tectum and reticular formation was observed in rats pretreated with 7.5 and 15 mg/kg AM. The present data suggest that although the therapeutic equivalent dose of 1.5 mg/kg AM had no appreciable effects on pentobarbitone sleep but caused reduced electrical activity in rats, higher doses have more profound effects on both indices.
Insights
Artemether (AM), an antimalarial drug, showed dose-dependent neurotoxic effects in rats. Higher AM doses prolonged sleep and altered brain electrical activity, indicating potential risks with increased usage.
Area of Science:
- Neuropharmacology
- Malariology
Background:
- Artemether (AM) is a key antimalarial drug, effective against resistant strains.
- Concerns exist regarding AM's neurotoxicity after high-dose or prolonged use.
Purpose of the Study:
- To investigate the effects of Artemether on pentobarbitone-induced sleep and electrophysiological activity in rats.
- To evaluate dose-dependent neurotoxicity of AM.
Main Methods:
- Wistar rats were administered varying doses of AM (1.5, 7.5, 15 mg/kg) or vehicle.
- Effects on pentobarbitone sleep onset and duration were assessed.
- Electroencephalogram (EEG) and electromyogram (EMG) recordings evaluated brain electrical activity.
Main Results:
- Single AM doses did not significantly alter pentobarbitone sleep.
- 7-day AM pretreatment dose-dependently prolonged pentobarbitone sleep.
- High-dose AM (15 mg/kg) showed CNS inhibitory effects; lower doses (1.5 mg/kg) reduced cortical activity, while higher doses caused desynchronization in specific brain regions.
Conclusions:
- Therapeutic doses of AM (1.5 mg/kg) had minimal impact on sleep but reduced electrical activity.
- Higher AM doses exhibit more significant neurotoxic effects, impacting both sleep and brain electrical patterns.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics Drugs: Barbiturates
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

